Back to round index.
Rank | Won-Lost | Spread | Old Rating | New Rating | Rating Change | Class | Player | Last Game | Next Game |
---|---|---|---|---|---|---|---|---|---|
1 | 1–0 | +331 | 1886 | 1886 | +0 | A | Wilde, Howard (#7/Eng) | 2W:600-269:#40 | #29 |
2 | 1–0 | +272 | 1669 | 1670 | +1 | A | Gillam, Simon (#14/Sco) | 1W:505-233:#29 | #40 |
3 | 1–0 | +210 | 2121 | 2121 | +0 | A | Gipson, Helen (#2/Sco) | 2W:456-246:#45 | #30 |
4 | 1–0 | +199 | 1875 | 1875 | +0 | A | Sim, Tony (#8/SGP) | 1W:560-361:#43 | #37 |
5 | 1–0 | +198 | 1597 | 1598 | +1 | A | McArthur, Jean (#15/USA) | 2W:532-334:#37 | #43 |
6 | 1–0 | +190 | 1894 | 1894 | +0 | A | Kantimathi, Sam (#6/USA) | 2W:559-369:#39 | #32 |
7 | 1–0 | +139 | 2028 | 2028 | +0 | A | Okwelogu, Chinedu (#3/NGA) | 2W:494-355:#35 | #34 |
8 | 1–0 | +136 | 1682 | 1682 | +0 | A | Delia, Jojo (#12/MLT) | 2W:404-268:#44 | #25 |
9 | 1–0 | +112 | 1672 | 1672 | +0 | A | Muscat, Cecil (#13/MLT) | 1W:415-303:#42 | #33 |
10 | 1–0 | +103 | 1589 | 1590 | +1 | B | Tate, Raymond (#17/Sco) | 1W:412-309:#33 | #42 |
11 | 1–0 | +95 | 1170 | 1197 | +27 | B | Ni Bhriain, Brid (#30/IRL) | 1W:444-349:#18 | #2 |
12 | 1–0 | +93 | 1277 | 1285 | +8 | B | Huitson, Nicky (#27/Eng) | 2W:441-348:#31 | #9 |
13 | 1–0 | +73 | 1915 | 1915 | +0 | A | Lipe, Chris (#5/USA) | 1W:409-336:#36 | #28 |
14 | 1–0 | +62 | 1884 | 1884 | +0 | A | Polatnick, Steve (#9/USA) | 2W:402-340:#41 | #27 |
15 | 1–0 | +58 | 1507 | 1508 | +1 | B | Kamath, Pramit (#21/IND) | 2W:389-331:#34 | #35 |
16 | 1–0 | +54 | 1790 | 1792 | +2 | A | Winter (#11/USA) | 2W:390-336:#23 | #31 |
17 | 1–0 | +49 | 1426 | 1434 | +8 | B | Barker, John (#22/AUS) | 2W:490-441:#25 | #44 |
18 | 1–0 | +29 | 1270 | 1296 | +26 | B | Hoskisson, Dave (#28/Eng) | 1W:360-331:#16 | #5 |
19 | 1–0 | +28 | 1932 | 1932 | +0 | A | Brousson, Theresa (#4/MLT) | 2W:413-385:#38 | #26 |
20 | 1–0 | +21 | 1572 | 1574 | +2 | B | Sandu, Dan (#19/ROM) | 1W:392-371:#32 | #39 |
21 | 1–0 | +2 | 1316 | 1333 | +17 | B | Meghen, Eileen (#26/IRL) | 1W:381-379:#24 | #4 |
22 | 0–1 | −2 | 1403 | 1391 | −12 | B | Saliba, Mario (#24/MLT) | 2L:379-381:#26 | #38 |
23 | 0–1 | −21 | 1187 | 1184 | −3 | B | Morris, Pam (#32/AUT) | 2L:371-392:#19 | #6 |
24 | 0–1 | −28 | 995 | 995 | +0 | C | Frendo, Pawlu (#38/MLT) | 1L:385-413:#4 | #24 |
25 | 0–1 | −29 | 1590 | 1573 | −17 | B | Synnott, Kevin (#16/Eng) | 2L:331-360:#28 | #36 |
26 | 0–1 | −49 | 1318 | 1311 | −7 | B | Waterworth, Martin (#25/AUS) | 1L:441-490:#22 | #12 |
27 | 0–1 | −54 | 1431 | 1429 | −2 | B | Mackenzie, Jayne (#23/Eng) | 1L:336-390:#11 | #41 |
28 | 0–1 | −58 | 1066 | 1065 | −1 | C | Caruana, Joe (#34/MLT) | 1L:331-389:#21 | #3 |
29 | 0–1 | −62 | 836 | 836 | +0 | C | Docherty, Paula (#41/Eng) | 1L:340-402:#9 | #23 |
30 | 0–1 | −73 | 1014 | 1014 | +0 | C | Xuereb, Alfred (#36/MLT) | 2L:336-409:#5 | #16 |
31 | 0–1 | −75 | 2156 | 2156 | +0 | A | Eldar, David (#1/AUS) | bye | |
32 | 0–1 | −93 | 1167 | 1160 | −7 | B | Mifsud, Paul (#31/MLT) | 1L:348-441:#27 | #11 |
33 | 0–1 | −95 | 1581 | 1563 | −18 | B | O'Rourke, Nuala (#18/NIr) | 2L:349-444:#30 | #45 |
34 | 0–1 | −103 | 1152 | 1151 | −1 | B | Frydenlund, Anlaug (#33/NOR) | 2L:309-412:#17 | #13 |
35 | 0–1 | −112 | 807 | 807 | +0 | C | Zammit, Reno (#42/MLT) | 2L:303-415:#13 | #17 |
36 | 0–1 | −136 | 757 | 757 | +0 | C | Seierstad, Taral (#44/NOR) | 1L:268-404:#12 | #22 |
37 | 0–1 | −139 | 1030 | 1030 | +0 | C | Doyle, Mary (#35/IRL) | 1L:355-494:#3 | #21 |
38 | 0–1 | −150 | 1512 | 1512 | +0 | B | Vella-Laurenti, Nicky (#20/MLT) | bye | |
39 | 0–1 | −190 | 970 | 970 | +0 | C | Takeda, Tadao (#39/JPN) | 1L:369-559:#6 | #19 |
40 | 0–1 | −198 | 1050 | 1049 | −1 | C | Alroy, Nancy (#37/ISR) | 1L:334-532:#15 | #8 |
41 | 0–1 | −199 | 793 | 793 | +0 | C | Eskil Åsmul (#43/NOR) | 2L:361-560:#8 | #15 |
42 | 0–1 | −210 | 408 | 408 | +0 | C | Loewenstein, Marion (#45/ISR) | 1L:246-456:#2 | #18 |
43 | 0–1 | −272 | 1173 | 1172 | −1 | B | Zammit, Albert (#29/MLT) | 2L:233-505:#14 | #7 |
44 | 0–1 | −331 | 949 | 949 | +0 | C | Morgan, Mary (#40/IRL) | 1L:269-600:#7 | #14 |
This report was generated by tsh version 3.320. For more information about tsh, please contact John Chew.